non-small-cell lung cancer

Open Access
Association Between PD-L1 Expression and Interstitial Lung Disease Risk in EGFR-mutant NSCLC Treated With EGFR-TKIs
YUTAKA TAKAHARA, RYUDAI ABE, SUMITO NAGAE, TAKUYA TANAKA, YOKO ISHIGE, IKUYO SHIONOYA, KOUICHI YAMAMURA, MASAFUMI NOJIRI and MASAHARU IGUCHI

In Vivo January 2026, 40 (1) 514-521; DOI: https://doi.org/10.21873/invivo.14215
Open Access
Survival Outcomes in Patients With Locally Advanced NSCLC Converted to Resectable Disease by Neoadjuvant Therapy
ECE DUYGU GULSEN, RASHAD ISMAYILOV, AYDAN FARZALIYEVA, MEHMET NEZIR RAMAZANOGLU, ARZU OGUZ, DALOKAY KILIC, ZAFER AKCALI and OZDEN ALTUNDAG

In Vivo January 2026, 40 (1) 522-531; DOI: https://doi.org/10.21873/invivo.14216
Open Access
The Effects of Nebivolol-Gefitinib-Loratadine Against Lung Cancer Cell Lines
JOSÉ LUIS MARTÍNEZ-LIRA, ELISABETH HERNÁNDEZ-GALLEGOS, MARÍA DE GUADALUPE CHÁVEZ-LÓPEZ, RICARDO VILLALOBOS-VALENCIA and JAVIER CAMACHO

In Vivo November 2024, 38 (6) 2688-2695; DOI: https://doi.org/10.21873/invivo.13746
Open Access
Comprehensive Assessment of the Clinical Risk Factors of Postoperative Adverse Events and Survival in Patients With Non-small-cell Lung Cancer
BEE-SONG CHANG, TAI-CHU PENG, KUN-HAN LUE, YI-FENG WU and CHUN-HOU HUANG

In Vivo May 2023, 37 (3) 1358-1364; DOI: https://doi.org/10.21873/invivo.13217
Open Access
Palliative Radiotherapy for Non-metastatic Non-small-cell Lung Cancer: Impact of Blood Test Results on Survival
CARSTEN NIEDER and KRISTIAN S. IMINGEN

In Vivo March 2023, 37 (2) 771-776; DOI: https://doi.org/10.21873/invivo.13140
Open Access
Fc Receptor Expression as a Prognostic Factor in Patients With Non-small-cell Lung Cancer
MIN HYE KIM, JEONG HEE LEE, JONG SIL LEE, DONG CHUL KIM, JUNG WOOK YANG, HYO JUNG AN, JI MIN NA, MEONG CHEOL SHIN and DAE HYUN SONG

In Vivo November 2022, 36 (6) 2708-2713; DOI: https://doi.org/10.21873/invivo.13006
You have access
Acquired EGFR C797G Mutation Detected by Liquid Biopsy as Resistance Mechanism After Treatment With Osimertinib: A Case Report
ELISA DE CARLO, MONICA SCHIAPPACASSI, GIACOMO PELIZZARI, TANIA BARESIC, ALESSANDRO DEL CONTE, BRIGIDA STANZIONE, VALENTINA DA ROS, ROBERTO DOLIANA, GUSTAVO BALDASSARRE and ALESSANDRA BEARZ

In Vivo September 2021, 35 (5) 2941-2945; DOI: https://doi.org/10.21873/invivo.12586
You have access
Coexistence of Emphysema With Non-small-cell Lung Cancer Predicts the Therapeutic Efficacy of Immune Checkpoint Inhibitors
YUSUKE TAKAYAMA, TAKASHI NAKAMURA, YUKI FUKUSHIRO, SHOHEI MISHIMA, KEN MASUDA and HIROYASU SHODA

In Vivo January 2021, 35 (1) 467-474; DOI: https://doi.org/10.21873/invivo.12280

Main menu

User menu

Search

non-small-cell lung cancer